ABOUT THE NEWSROOM

Here you will find media contacts, plus the latest news, stories and insights from Lundbeck US. Lundbeck is a global pharmaceutical company solely focused on the brain, and our 900+ U.S. employees are committed to improving the lives of people affected by psychiatric and neurological disorders.

Science
Science
Perspective
PERSPECTIVES
our-impact
Our Impact
press-release
News Releases
Lundbeck to Showcase New VYEPTI® (eptinezumab-jjmr) Data at 63rd Annual Scientific Meeting of the American Headache Society (AHS)
News Releases
Lundbeck to Showcase New VYEPTI® (eptinezumab-jjmr) Data at 63rd Annual Scientific Meeting of the American Headache Society (AHS)
What About the Moms? Supporting the Mental Health of Working Mothers
Our Impact
What About the Moms? Supporting the Mental Health of Working Mothers
Patient Groups Recognize Lundbeck as a Top Company for Corporate Reputation for 6th Straight Year
News Releases
Patient Groups Recognize Lundbeck as a Top Company for Corporate Reputation for 6th Straight Year
Video: Harnessing Data and Technology to Predict Community Mental Health Needs
Our Impact
Video: Harnessing Data and Technology to Predict Community Mental Health Needs
Lake County Life Science Leaders Join Forces to Launch New COVID-19 Vaccine Clinics in Zion
News Releases
Lake County Life Science Leaders Join Forces to Launch New COVID-19 Vaccine Clinics in Zion

This site contains medical information that is intended for residents of the United States only and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site are subject to the terms and conditions as set out in our Privacy Policy and Terms of Use. 

© Copyright 2021 Lundbeck. All rights reserved.